Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Use of subcutaneous interstitial fluid glucose to estimate blood glucose: revisiting delay and sensor offset.

Rebrin K, Sheppard NF Jr, Steil GM.

J Diabetes Sci Technol. 2010 Sep 1;4(5):1087-98.

PMID:
20920428
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A bihormonal closed-loop artificial pancreas for type 1 diabetes.

El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER.

Sci Transl Med. 2010 Apr 14;2(27):27ra27. doi: 10.1126/scitranslmed.3000619.

PMID:
20393188
[PubMed - indexed for MEDLINE]
Free Article
3.

Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes.

Kanderian SS, Weinzimer S, Voskanyan G, Steil GM.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1047-57.

PMID:
20144418
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.

Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1031-8.

PMID:
20144416
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.

Bruttomesso D, Farret A, Costa S, Marescotti MC, Vettore M, Avogaro A, Tiengo A, Dalla Man C, Place J, Facchinetti A, Guerra S, Magni L, De Nicolao G, Cobelli C, Renard E, Maran A.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1014-21.

PMID:
20144414
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial.

Hovorka R, Allen JM, Elleri D, Chassin LJ, Harris J, Xing D, Kollman C, Hovorka T, Larsen AM, Nodale M, De Palma A, Wilinska ME, Acerini CL, Dunger DB.

Lancet. 2010 Feb 27;375(9716):743-51. doi: 10.1016/S0140-6736(09)61998-X. Epub 2010 Feb 4.

PMID:
20138357
[PubMed - indexed for MEDLINE]
Free Article
7.

Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.

Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV.

Diabetes Care. 2008 May;31(5):934-9. doi: 10.2337/dc07-1967. Epub 2008 Feb 5.

PMID:
18252903
[PubMed - indexed for MEDLINE]
8.

Feasibility of automating insulin delivery for the treatment of type 1 diabetes.

Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF.

Diabetes. 2006 Dec;55(12):3344-50.

PMID:
17130478
[PubMed - indexed for MEDLINE]
Free Article
9.

Evaluation of the effect of gain on the meal response of an automated closed-loop insulin delivery system.

Panteleon AE, Loutseiko M, Steil GM, Rebrin K.

Diabetes. 2006 Jul;55(7):1995-2000.

PMID:
16804068
[PubMed - indexed for MEDLINE]
Free Article
10.

Closed-loop insulin delivery - what lies between where we are and where we are going?

Steil GM, Rebrin K.

Expert Opin Drug Deliv. 2005 Mar;2(2):353-62. Review.

PMID:
16296759
[PubMed - indexed for MEDLINE]
11.

Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system.

Jones SM, Quarry JL, Caldwell-McMillan M, Mauger DT, Gabbay RA.

Diabetes Technol Ther. 2005 Apr;7(2):233-40.

PMID:
15857224
[PubMed - indexed for MEDLINE]
12.

Modeling insulin action for development of a closed-loop artificial pancreas.

Steil GM, Clark B, Kanderian S, Rebrin K.

Diabetes Technol Ther. 2005 Feb;7(1):94-108.

PMID:
15738707
[PubMed - indexed for MEDLINE]
13.

Closed-loop insulin delivery-the path to physiological glucose control.

Steil GM, Panteleon AE, Rebrin K.

Adv Drug Deliv Rev. 2004 Feb 10;56(2):125-44. Review.

PMID:
14741112
[PubMed - indexed for MEDLINE]
14.

Modeling beta-cell insulin secretion--implications for closed-loop glucose homeostasis.

Steil GM, Rebrin K, Janowski R, Darwin C, Saad MF.

Diabetes Technol Ther. 2003;5(6):953-64.

PMID:
14709197
[PubMed - indexed for MEDLINE]
15.

Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin.

Mittelman SD, Bergman RN.

Am J Physiol Endocrinol Metab. 2000 Sep;279(3):E630-7.

PMID:
10950832
[PubMed - indexed for MEDLINE]
Free Article
16.

Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia.

Mittelman SD, Fu YY, Rebrin K, Steil G, Bergman RN.

J Clin Invest. 1997 Dec 15;100(12):3121-30.

PMID:
9399959
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

In praise of the hyperglycemic clamp. A method for assessment of beta-cell sensitivity and insulin resistance.

Elahi D.

Diabetes Care. 1996 Mar;19(3):278-86. Review.

PMID:
8742583
[PubMed - indexed for MEDLINE]
18.

Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.

Rebrin K, Steil GM, Mittelman SD, Bergman RN.

J Clin Invest. 1996 Aug 1;98(3):741-9.

PMID:
8698866
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Exaggerated hyperglycemia after a pizza meal in well-controlled diabetes.

Ahern JA, Gatcomb PM, Held NA, Petit WA Jr, Tamborlane WV.

Diabetes Care. 1993 Apr;16(4):578-80.

PMID:
8462382
[PubMed - indexed for MEDLINE]
20.

Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin.

Rebrin K, Steil GM, Getty L, Bergman RN.

Diabetes. 1995 Sep;44(9):1038-45.

PMID:
7657026
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk